当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析

丸美生物

(603983)

  

流通市值:99.57亿  总市值:99.57亿
流通股本:4.01亿   总股本:4.01亿

丸美生物(603983)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.01亿元,每股收益0.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益349257.69万元,未分配利润206671.73万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产469030.04万元,负债119772.36万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入881,288,902.193,459,318,0842,450,380,539.411,764,646,729.2
营业总成本761,891,108.233,214,916,856.762,206,220,208.731,550,885,924.71
其他经营收益
营业利润122,876,460.7296,611,057.33299,077,057.09229,120,922.85
利润总额123,226,746.62295,731,444.58298,521,477.37228,852,497.48
净利润100,997,752.2246,742,825.83246,649,316.64174,712,447.04
每股收益
其他综合收益-24,389.15-22,246.12-73,087.1-112,116.33
综合收益总额100,973,363.05246,720,579.71246,576,229.54174,600,330.71
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,313,458,719.722,235,887,239.432,594,081,776.342,559,616,186.95
非流动资产:
非流动资产合计2,376,841,684.442,377,567,587.62,252,541,082.772,198,728,829.81
资产总计4,690,300,404.164,613,454,827.034,846,622,859.114,758,345,016.76
流动负债:
流动负债合计1,177,205,446.121,198,807,998.541,436,832,268.971,322,663,067.44
非流动负债:
非流动负债合计20,518,103.8820,471,583.6218,504,584.4616,121,842.48
负债合计1,197,723,5501,219,279,582.161,455,336,853.431,338,784,909.92
所有者权益(或股东权益):
归属于母公司股东权益合计3,432,153,477.113,331,157,901.883,323,476,059.973,354,205,421.09
股东权益合计3,492,576,854.163,394,175,244.873,391,286,005.683,419,560,106.84
负债和股东权益合计4,690,300,404.164,613,454,827.034,846,622,859.114,758,345,016.76
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计930,399,940.573,998,479,620.312,558,200,460.241,839,573,690.11
经营活动现金流出小计893,206,433.893,724,603,217.992,399,327,220.711,660,043,855.72
经营活动产生的现金流量净额37,193,506.68273,876,402.32158,873,239.53179,529,834.39
投资活动产生的现金流量:
投资活动现金流入小计58,383,110.73193,442,309.22157,352,229.43157,330,350.37
投资活动现金流出小计102,559,880.66507,377,767.2324,299,465.9235,365,414.78
投资活动产生的现金流量净额-44,176,769.93-313,935,457.98-166,947,236.47-78,035,064.41
筹资活动产生的现金流量:
筹资活动现金流入小计122,193,293.331,437,822,791.35440,309,091.9415,388,536.34
筹资活动现金流出小计135,979,845.262,035,556,308.49823,106,804.3772,550,724.5
筹资活动产生的现金流量净额-13,786,551.93-597,733,517.14-382,797,712.4-357,162,188.16
汇率变动对现金及现金等价物的影响-17,794.29-6,647.4925,235.78124,244.98
现金及现金等价物净增加额-20,787,609.47-637,799,220.29-390,846,473.56-255,543,173.2
期末现金及现金等价物余额920,473,180.18941,260,789.651,188,213,536.381,323,516,836.74
补充资料:
现金及现金等价物的净增加额--637,799,220.29--255,543,173.2
最新报告期:2026-05-11
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
长城证券黄淑妍0.800.951.112026-05-11
长江证券李锦,罗祎0.820.920.992026-05-11
浙商证券周舒怡,罗晓婷0.790.931.032026-05-05
华源证券丁一0.811.031.152026-05-01
中金公司徐卓楠,袁华远,黄蔓琪0.870.99--2026-04-30
TOP↑